|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 2
Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about biosimilar development trends.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about biosimilar development trends.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5